DOSAGE FORM FOR TREATING INFLUENZA AND ACUTE VIRAL RESPIRATORY TRACT INFECTIONS

摘要

The invention relates to the chemical and pharmaceutical industry and to medicine, and concerns a novel liquid dosage form for oral administration for the treatment and prophylaxis of influenza and acute viral respiratory tract infections, said dosage form comprising 2-(imidazol-4-yl)-ethanamide pentanedioic-1,5 acid in an effective amount, and excipients.